ABSTRACT

Introduction: Pharmacy-based point-of-care testing has long had the potential to improve patient access to timely care, but adoption has been slowed by financial and regulatory barriers. The COVID-19 pandemic reduced or temporarily eliminated many of the barriers to pharmacy-based testing. This review examines how the changes brought on by may impact pharmacy-based testing after the pandemic.

Areas covered: This review searched peer-reviewed, lay, and regulatory literature to explore the implementation of pharmacy-based COVID-19 testing. This includes a review of regulatory and financial changes that removed barriers to testing. Additionally, it reviews the literature related to the growth of pharmacy-based testing.

Expert opinion: It is clear that the COVID-19 pandemic created an awareness and opportunity for pharmacy-based point-of-care testing. The changes made in response to the pandemic have the potential to increase the role of pharmacy-based testing, but additional regulatory changes and wider pharmacy adoption are still needed to maximize the value of such services.

摘要

简介：基于药房的即时检验一直有可能改善患者获得及时护理的机会，但由于财务和监管障碍，其采用速度已经放缓。COVID-19 大流行减少或暂时消除了药房检测的许多障碍。本次审查探讨了大流行后由 带来的变化可能如何影响基于药房的检测。

涵盖的领域：本综述检索了同行评审、非专业和监管文献，以探索基于药房的 COVID-19 测试的实施。这包括对消除测试障碍的监管和财务变化的审查。此外，它还回顾了与药房检测增长相关的文献。

专家意见：很明显，COVID-19 大流行为基于药房的即时检测创造了意识和机会。为应对大流行而做出的改变有可能增加基于药房的检测的作用，但仍需要进一步的监管变化和更广泛的药房采用，以最大限度地提高此类服务的价值。